The drug is known as EIDD-2801. It works by interfering with the coronavirus' ability to make copies of itself once it infects a cell. In that regard it's similar to remdesivir, a drug currently being tested in COVID-19 patients. EIDD-2801 has one major advantage over remdesivir: It can be taken as a pill, whereas remdesivir must be given intravenously.
npr
No comments:
Post a Comment